Research progress of cellular coagulation factor ⅩⅢ

Abstract

Abstract: Coagulation factor ⅩⅢ (FⅩⅢ) is a member of the plasma transglutaminase family.Plasma FⅩⅢ (pFⅩⅢ)consists of two catalytic A subunits and two non-catalytic B subunits(FⅩⅢ-A2B2)combined with non-covalent bonds to form a heterotetramer.The cellular FⅩⅢ(cFⅩⅢ) exists in a form of A subunit homodimer(FⅩⅢ-A2).Although it is currently believed that cellular FⅩⅢ can be internalized and externalized from the cell through an unknown mechanism and cross-linked extracellular substrates to function in a variety of pathophysiological events,its specific functions and mechanisms need to be clarified by further systematic research.

Key words: cellular coagulation factor ⅩⅢ, haemostasis, phagocytosis, inflammation

CLC Number:

R363.1

XUE Yu-jia, LI Zi-jian. Research progress of cellular coagulation factor ⅩⅢ[J]. Basic & Clinical Medicine, 2021, 41(11): 1680-1683.

References

[1]Hamedani NS,Biswas A,Rudan O,et al.Functional and structural charac-terization of nucleic acid ligands that bind to activated coagulation factor ⅩⅢ[J].J Clin Med,2021,10:677.doi:10.3390/jcm10040677.
[2]Protopopova Anna D,Ramirez Andrea,Klinov Dmitry V,et al.Factor ⅩⅢ topology:organization of B subunits and changes with activation studied with single-molecule atomic force microscopy[J].Thromb Haemost,2019,17:737-748.
[3]Beckers C,Simpson KR,Griffin KJ,et al.Cre/lox studies identify resident macrophages as the major source of circulating coagulation factor ⅩⅢ-A[J].Arterioscler Thromb Vasc Biol,2017,37:1494-1502.
[4]Cordell PA,Kile BT,Standeven KF,et al.Association of coagulation factor ⅩⅢ-A with Golgi proteins within monocyte-macrophages:implications for subcellular trafficking and secretion[J].Blood,2010,115:2674.doi:10.1182/blood-2009-08-231316.
[5]Whyte Claire S,Morrow Gael B,Baik Nagyung,et al.Exposure of plasminogen and a novel plasminogen receptor,Plg-RKT,on activated human and murine platelets[J].Blood,2021,137:248-257.
[6]B Baráth,R Bogáti,T Miklós,et al.Effect of α2-plasmin inhibitor heterogeneity on the risk of venous thromboem-bolism[J].Thromb Res,2021,203:110-116.
[7]Bagoly Z,B Baráth,R Orbán-Kálmándi,et al.Incorpora-tion of α2-plasmin inhibitor into fibrin clots and its association with the clinical outcome of acute ischemic stroke patients[J].Biomolecules,2021,11:347.doi:10.3390/biom11030347.
[8]Singh S,J Dodt,Volkers P,et al.Structure functional insights into calcium binding during the activation of coagulation factor ⅩⅢ A[J].Sci Rep,2019,9.doi:10.1038/s41598-019-47815-z.
[9]Fekete A,I Komáromi,Mucs D.On the early events of the calcium-induced activation of coagulation factor ⅩⅢ-A 2 and tissue transglutaminase:an in silico study[J].J Biomol Struct Dyn,2019,38:1-27.
[10]Chin WY,He CY,Chow TW,et al.Adenylate kinase 4 promotes inflammatory gene expression via hif1α and AMPK in macrophages[J].Front Immunol,2021,12:630318.doi:10.3389/fimmu.2021.630318.
[11]D Töröcsik,L Széles,Paragh G,et al.Factor ⅩⅢ-A is involved in the regulation of gene expression in alternatively activated human macrophages[J].Thromb Haemost,2010,103:709-717.
[12]A Sárváry,SzCs S,Balogh I,et al.Possible role of factor ⅩⅢ subunit A in Fcγ and complement receptor-mediated phagocytosis[J].Cell Immunol,2004,228:81-90.
[13]Soendergaard C,Kvist PH,Seidelin JB,et al.Systemic and intestinal levels of factor ⅩⅢ-A:the impact of inflam-mation on expression in macrophage subtypes[J].J Gastroenterol,2016,51:796-807.
[14]Aljohani H,Senbanjo LT,Chellaiah MA.Methylsulfonylmethane increases osteogenesis and regulates the mineralization of the matrix by transglutami-nase 2 in SHED cells[J].PLoS One,2019,14:e0225598.doi:10.1371/journal.pone.0225598.
[15]Al-Jallad HF,Myneni VD,Piercy-Kotb SA,et al.Plasma membrane factor ⅩⅢA transglutaminase activity regulates osteoblast matrix secretion and d-eposition by affecting microtubule dynamics[J].PLoS One,2011,6:e15893.doi:10.1371/journal.pone.0015893.
[16]Wang S,Kaartinen MT.Cellular factor ⅩⅢA transgluta-minase localizes in caveolae and regulates caveolin-1 phosphory-lation,homo-oligomerization and c-Src signaling in osteo-blasts[J].J Histochem Cytochem,2015,63:829-841.
[17]Sun H,Kaartinen MT.Assessment of expression and specific activities of transglutaminases TG1,TG2 and FⅩⅢ-A during osteoclastogenesis[J].Analytical Biochem,2019,591.doi:10.1016/j.ab.2019.113512.
[18]Sun,Huifang,Kaartinen,et al.Transglutaminase activity regulates differentiation,migration and fusion of osteoclasts via affecting actin dynamics[J].J Cell Physiol,2018,233:7497-7513.
[19]Porrello A,Leslie PL,Harrison EB,et al.Factor ⅩⅢA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking[J].Nat Commun,2018,9:1988.doi:10.1038/s41467-018-04355-w.
[20]Pavord ID,Corren J.Biomarkers of type 2 airway inflammation in airway disease:and then there were two[J]. J Allergy Clin Immunol Pract,2020,8:2640-2642.
[21]Gualtierotti R,Ingegnoli F,Boscolo M,et al.Tocilizumab effects on coagulation Factor ⅩⅢ in patients with rheumatoid arthritis[J].Adv Ther,2019,36:3494-3502.
[22]Hoppe B,Schwedler C,Haibel H,et al.Fibrinogen,factor ⅩⅢ and α2 -antiplasmin genotypes are associated with inflammatory activity and anti-citrullinated protein antibodies[J].Thromb Res,2020,191:90-96.
[23]Raval Jay S,Berg Aaron N,Djokic M,et al.Factor ⅩⅢ subunit A im-munohistochemical expression is associated with inferior outcomes in acute promyelocytic leukemia[J].Appl Immunohistochem Mol Morphol,2018,26:202-205.
[24]B Kárai,Gyurina K,Ujfalusi A,et al.Expression patterns of coagulation factor ⅩⅢ subunit A on leukemic lymphoblasts correlate with clinical outcome and genetic subtypes in childhood B-cell progenitor acute lympho-blastic leukemia[J].Cancers,2020,12:2264.doi:10.3390/cancers12082264.
[25]Katalin,Gyurina,Bettina,et al.Coagulation FⅩⅢ-A protein expression defines three novel sub-populations in pediatric B-cell progenitor acute lymphoblastic leukemia characterized by distinct gene expression signatures[J].Front Oncol,2019,9:1063-1063.